fda tirzepatide compounding Moves to Permanently Close the Door on Compounded GLP-1s GLP-1 compounding is still in

Patients currently on MEDVi's platform should monitor for any changes in medication availability or pricing

If this person was skipping meals because they are not hungry, you can see how difficult it would be to reach this recommendation

Retatrutide is under active investigation for its potential roles in metabolic regulation , energy expenditure, glucose balance, and multi-receptor hormone activity

"These actions are aimed to safeguard consumers from drugs for which the FDA cannot verify quality, safety, or efficacy," the FDA said

Last clinically reviewed: 12 June 2026 Published 9 August 2025 There is no fixed list of supplements to take with Wegovy that applies to everyone